Introduction: Respiratory pathogens pose a complex challenge for public health systems. In the winter of 2023, multiple respiratory pathogens showed staggered epidemic waves. Additionally, co-infections involving various pathogens were observed, resulting in significant disease burdens. Understanding the epidemiological dynamics of these pathogens is essential for supporting public health systems in the prevention and control of respiratory infectious diseases.
Methods: Respiratory samples were collected from patients in Beijing presenting with influenza-like symptoms to detect 27 respiratory pathogens using multiplex qPCR.
Results: Four distinct epidemic waves were identified. The first wave was a pre-winter outbreak of (). This was then followed by successive waves of influenza A and B viruses. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibited a resurgence by the end of February 2024. Age-dependent susceptibility varied, with SARS-CoV-2 and influenza A/B peaking in the 30-40-year age group. Conversely, adenovirus, rhinovirus, , (), and () were more common in adolescents and the elderly. Furthermore, 18.8% of cases were identified as co-infections with more than two pathogens. was found to frequently co-infect with viral and bacterial pathogens.
Conclusions: Respiratory pathogens exhibited different prevalence trends during the first influenza season following the COVID-19 pandemic. Influenza viruses showed a higher peak incidence and delayed seasonality. Moreover, the co-circulation of viral and bacterial infections increased the complexity of respiratory infections. Interestingly, staggered epidemic waves between SARS-CoV-2 and influenza A/B viruses were observed. Consequently, SARS-CoV-2 may become a seasonal virus, causing epidemics alongside influenza viruses. However, further research is needed to elucidate its epidemiological patterns. The co-circulation of these epidemic viruses and other respiratory pathogens underscores the need for enhanced diagnostic and intervention strategies, including vaccination campaigns.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11807245 | PMC |
| http://dx.doi.org/10.46234/ccdcw2025.018 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Frequency of Culture-proven Bacterial Infection and Radiographic Pneumonia in Pediatric Heart Transplant Recipients.
Pediatr Infect Dis J
March 2025
Divisions of Pediatric Emergency Medicine and Pediatric Infectious Diseases, Baylor College of Medicine, Houston, Texas.
Background: Infection is a leading cause of death after pediatric heart transplants (PHTs). Understanding of common pathogens is needed to guide testing strategies and empiric antibiotic use.
Methods: We conducted a 3-center retrospective study of PHT recipients ≤18 years old presenting to cardiology clinics or emergency departments (EDs) from 2010 to 2018 for evaluation of suspected infections within 2 years of transplant.
Development and validation of a high throughput multiplex immunofluorescence assay to detect all human immunoglobulin isotypes and subclasses in human fluids.
J Immunol
March 2025
Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
Antibodies in human milk protect infants against infections, but currently no assay is described that is able to simultaneously measure all 9 antibody isotypes and subclasses immunoglobulins in human fluids, such as human milk. Our cohort "Protecting against Respiratory tract Infections through human Milk Analysis" (PRIMA) is focused on the relation between the occurrence of respiratory infections during the first year of life and concentration of maternal antibodies in breastfeeding. We developed and successfully validated a multiplex assay that is able to measure all nine antibody isotypes and subclasses in human plasma and milk (regardeless of the pathogen specificity), using a small sample volume.
View Article and Find Full Text PDFAbsence of c-Maf and IL-10 enables type I IFN enhancement of innate responses to LPS in alveolar macrophages.
J Immunol
March 2025
Department of Veterinary and Animal Sciences, University of Massachusetts Amherst, Amherst, MA, United States.
Alveolar macrophages (AMs) are lung-resident myeloid cells and airway sentinels for inhaled pathogens and environmental particles. While AMs can be highly inflammatory in response to respiratory viruses, they do not mount proinflammatory responses to all airborne pathogens. For example, we previously showed that AMs fail to mount a robust proinflammatory response to Mycobacterium tuberculosis.
View Article and Find Full Text PDFWe measured stability of infectious influenza A(H5N1) virus in irradiated raw milk and wastewater and on surfaces. We found a relatively slow decay in milk, indicating that contaminated milk and fomites pose transmission risks. Although the risk is low, our results call for caution in milk handling and disposal from infected cattle.
View Article and Find Full Text PDFVaccine Effectiveness Dynamics against Influenza and SARS-CoV-2 in Community-tested Patients in France 2023-2024.
Emerg Microbes Infect
March 2025
Hospices Civils de Lyon (HCL), Centre National des virus des infections respiratoires, Institut des Agents Infectieux, Laboratoire de Virologie, Lyon, France.
Background: The epidemiology of respiratory viruses and vaccine effectiveness (VE) in the community is not well described. This study assessed VE against a positive test of influenza (VEf) and SARS-CoV-2 (VECov).
Methods: Data from two large networks of community-based laboratories in France were collected during standard of care in the 2023-2024 epidemic season (n = 511,083 RT-PCR tests).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!